The LUNGevity Foundation is now accepting Letters of Intent for its 2025 Mid-Career “Bridge to Breathe” Research Award, offering $150,000 over two years to support associate-level physician-scientists whose lung cancer clinical research programs require bridge funding while reapplying for major federal or equivalent grants.
Who is eligible?
Applicants must:
-
Hold the rank of associate professor with tenure (or equivalent)
-
Demonstrate prior success with NIH R01 (or equivalent) funding
-
Show strong publication history in lung cancer research
-
Have submitted a major federal grant application (e.g., NIH R01) within the last 6 months that was not funded
-
Not hold any concurrent multi-year funding (e.g., NIH, DOD, ACS, institutional startup/retention funds)
Funding at a glance:
-
$150,000 total ($75,000/year for 2 years)
-
Research must be clinical and focused on lung cancer
-
Funded projects must meet annual milestones
-
Progress and financial reporting is required
Research focus:
This award is intended to sustain clinically relevant lung cancer research at a critical time when other funding may have lapsed. The project must clearly demonstrate clinical impact and feasibility for federal-level resubmission.
Key deadlines:
-
Full Application Deadline: May 12, 2025 (11:59 PM EDT)
-
Award Notification: Late Summer 2025
-
Award Start Date: November 1, 2025
Where to apply:
Submit all materials via ProposalCentral. Only selected applicants will be invited to submit full applications following LOI review.
Contact and details:
Visit www.lungevity.org for full program guidelines and application support.